Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

Background: Neoadjuvant chemotherapy (NACT) with TPF (docetaxel, cisplatin, and 5FU) is one of the treatment options in very locally advanced oral cancer with a survival advantage over PF (cisplatin and 5FU). TP (docetaxel and cisplatin) has shown promising results with a lower rate of adverse events but has never been compared to TPF.

Methods: In this phase 3 randomized superiority study, adult patients with borderline resectable locally advanced oral cancers were randomized in a 1:1 fashion to either TP or TPF.

Directly Knitted Hierarchical Porous Organometallic Polymer-Based Self-Supported Single-Site Catalyst for CO Hydrogenation in Water.

In recent times, heterogenization of homogeneous molecular catalysts onto various porous solid support structures has attracted significant research focus as a method for combining the advantages of both homogeneous as well as heterogeneous catalysis. The design of highly efficient, structurally robust and reusable heterogenized single-site catalysts for the CO hydrogenation reaction is a critical challenge that needs to be accomplished to implement a sustainable and practical CO -looped renewable energy cycle. This study demonstrated a heterogenized catalyst [Ir-HCP-(B/TPM)] containing a molecular Ir-abnormal N-heterocyclic carbene (Ir-aNHC) catalyst self-supported by hierarchical porous hyper-crosslinked polymer (HCP), in catalytic hydrogenation of CO to inorganic formate (HCO ) salt that is a prospective candidate for direct formate fuel cells (DFFC).

Analysis of Differential Gene Expression and Core Canonical Pathways Involved in the Epithelial to Mesenchymal Transition of Triple Negative Breast Cancer Cells by Ingenuity Pathway Analysis.

Triple Negative Breast Cancer (TNBC) is a malignant form of cancer with very high mortality and morbidity. Epithelial to Mesenchymal Transition (EMT) is the most common pathophysiological change observed in cancer cells of epithelial origin that promotes metastasis, drug resistance and cancer stem cell formation. Since the information regarding differential gene expression in TNBC cells and cell signaling events leading to EMT is limited, this investigation was done by comparing transcriptomic data generated by RNA isolation and sequencing of a EMT model TNBC cell line in comparison to regular TNBC cells.

Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit.

Background: The data regarding the use of neoadjuvant chemotherapy in technically unresectable head and neck cancer (HNC) is limited and real-world studies are needed to look for the efficacy and toxicities of this approach.

Patients And Methods: This is a retrospective study conducted in the Medical Oncology department of our hospital. All technically unresectable HNC patients who underwent neoadjuvant chemotherapy between May 2018 and May 2020 were included in this analysis.

Metal-Terpyridine Assembled Functional Materials for Electrochromic, Catalytic and Environmental Applications.

Molecular assembly induced by metal-terpyridine-based coordinative interactions has become an emergent research topic due to its ease of synthesis and diverse applications. This article highlights recent significant developments in the metal-terpyridine-based supramolecular architectures. At first, the design aspect of the molecular building blocks has been described, followed by elaboration on how the ligand backbone plays an important role for achieving different dimensionalities of the resulting assemblies which exhibit a wide range of potential applications.

Audit of Demographics, Treatment Patterns and Outcomes of Differentiated Thyroid Cancers Treated with Tyrosine Kinase Inhibitors.

The real-world patterns of TKI use in differentiated thyroid cancer (DTC) are largely governed by the accessibility and financial feasibility of the patient with more sorafenib use compared to lenvatinib. There are limited data available on the toxicity profile, safety and tolerance of sorafenib and lenvatinib in DTC. Hence, we audited our practice on DTC.

An Audit of Systemic Therapy in Medullary Carcinoma Thyroid.

There is a paucity of evidence of the impact of sorafenib on MCT and it is the preferred therapy used in India. We decided to do an audit of all patients of MCT who were referred to us for systemic therapy. The objective of this exercise was to identify the treatment pattern, outcomes, and adverse events with therapy in MCT.

Tris-NHC-propagated self-supported polymer-based Pd catalysts for heterogeneous C-H functionalization.

Three-dimensionally propagated imidazolium-containing mesoporous coordination polymer and organic polymer-based platforms were successfully exploited to develop single-site heterogenized Pd-NHC catalysts for oxidative arene/heteroarene C-H functionalization reactions. The catalysts were efficient in directed arene halogenation, and nondirected arene and heteroarene arylation reactions. High catalytic activity, excellent heterogeneity and recyclability were offered by these systems making them promising candidates in the area of heterogeneous C-H functionalization, where efficient catalysts are still scarce.

Coordination Booster-Catalyst Assembly: Remote Osmium Outperforming Ruthenium in Boosting Catalytic Activity.

Presented herein is a set of bimetallic and trimetallic "coordination booster-catalyst" assemblies in which the coordination complexes [Ru (terpy) ] and [Os (terpy) ] acted as boosters for enhancement of the catalytic activity of [Ru (NHC)(para-cymene)]-based catalytic site. The boosters accelerated the oxidative loss of para-cymene from the catalytic site to generate the active catalyst during the oxidation of alkenes and alkynes into corresponding aldehydes, ketones and diketones. It was found that the boosting efficiency of the [Os (terpy) ] units was considerably higher than its congener [Ru (terpy) ] unit in these assemblies.

Osteosarcoma journey over two decades in India: Small steps, big changes.

Background: The management of osteosarcoma is challenging especially in lower-income and middle-income countries, and there is an unmet need to evolve efficient and sustainable chemotherapy regimens.

Methods: We compared the outcomes in nonmetastatic osteosarcoma patients treated with three sequential non-high-dose methotrexate-based combination chemotherapy protocols at a single tertiary care center over two decades. The first protocol, OGS-99, involved dose-intense, alternating dyads of three drugs: doxorubicin (Dox), cisplatin (CDDP), and ifosfamide (Ifo).